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Death is a medical occurrence that has social, legal, religious and 
cultural consequences requiring common clinical standards for its 
diagnosis and legal regulation.[1] There is no documented case of a 
person who fulfils the preconditions and criteria for brain death ever 
subsequently developing any return of brain function.[2,3]
Clear medical standards for death certification augment the quality 
and rigor of death determination.[4-6] Currently there are no clinical 
guidelines on death determination in South Africa (SA), with clinicians 
using available international guidelines, which vary markedly and are 
not always applicable to the SA context.[7-10] The World Federation 
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Death is a medical occurrence that has social, legal, religious and cultural consequences requiring common clinical standards for its diagnosis 
and legal regulation. This document compiled by the Critical Care Society of Southern Africa outlines the core standards for determination 
of death in the hospital context. It aligns with the latest evidence-based research and international guidelines and is applicable to the South 
African context and legal system. The aim is to provide clear medical standards for healthcare providers to follow in the determination 
of death, thereby promoting safe practices and high-quality care through the use of uniform standards. Adherence to such guidelines will 
provide assurance to medical staff, patients, their families and the South African public that the determination of death is always undertaken 
with diligence, integrity, respect and compassion, and is in accordance with accepted medical standards and latest scientific evidence.
The consensus guidelines were compiled using the AGREE II checklist with an 18-member expert panel participating in a three-round 
modified Delphi process. Checklists and advice sheets were created to assist with application of these guidelines in the clinical environment 
(https://criticalcare.org.za/resource/death-determination-checklists/).
Key points
• Brain death and circulatory death are the accepted terms for defining death in the hospital context.
• Death determination is a clinical diagnosis which can be made with complete certainty provided that all preconditions are met.
• The determination of death in children is held to the same standard as in adults but cannot be diagnosed in children <36 weeks’ corrected 
gestation.
• Brain-death testing while on extra-corporeal membrane oxygenation is outlined.
• Recommendations are given on handling family requests for accommodation and on consideration of the potential for organ donation.
• The use of a checklist combined with a rigorous testing process, comprehensive documentation and adequate counselling of the family 
are core tenets of death determination. This is a standard of practice to which all clinicians should adhere in end-of-life care.
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of Societies of Intensive and Critical Care Medicine (WFSICCM) 
recently published a document, based on current literature, aiming to 
standardise terminology and establish minimum testing standards 
across the world.[5] In order to be applicable over a range of legal 
jurisdictions, some sections of this document are necessarily broad, 
making application to the local context challenging. There is therefore 
a need to align the WFSICCM document with the SA context and legal 
system, and to provide clear guidance to SA practitioners and the public.
The aims of this document are to provide guidelines for healthcare 
providers for the testing process, and to answer key questions that 
commonly arise when medical professionals are called upon to 
determine death in SA. The objectives are to:
• provide clear medical standards for healthcare providers in the 
determination of death, in order to promote safe practice and avoid 
diagnostic errors in the determination of death
• provide assurance to patients, their families and the SA public that 
determination of death is undertaken with diligence, integrity, 
respect and compassion and in accordance with accepted medical 
standards and societal expectations
• create a checklist for brain death and circulatory death determination.
Methods
An expert panel was constituted and reviewed current evidence 
and compiled consensus-based recommendations for the minimum 
standards required for death determination, applicable in the SA 
context, using a modified Delphi process. All statements in this 
guideline are considered strong recommendations. In cases where 
evidence is less strong, the term ‘suggested’ is used to indicate 
a lower level of evidence. Statements are intentionally similar 
to international documents in the interests of commonality of 
approach. Recommendations are aligned with the best interests of 
patients and their families.
Panel recruitment
Expert panel members were recruited through the Critical Care 
Society of Southern Africa (CCSSA) as experts in the field of death 
determination and end-of-life care representing a broad range of 
disciplines within critical care (neurosurgery, paediatrics, obstetrics 
and gynaecology, surgery, anaesthesiology, nursing, ethics). Informed 
consent was given by the expert panel with acknowledgement that 
they would be identifiable in the publication (Appendix 1 - 3: http://
samj.org.za/public/sup/15200-1.pdf). The study methodology was 
approved by the University of Cape Town Human Research Ethics 
Committee (HREC 476/2019).
Delphi process
A literature search of Pubmed, Web of Science, SCOPUS and the 
grey literature was conducted by the steering committee of the expert 
panel and a professional librarian to identify national and professional 
society guidelines in death determination, and their supporting 
evidence, for review (http://samj.org.za/public/sup/15200-2.pdf). A 
modified Delphi approach was used with adherence to the Appraisal 
of Guidelines for Research and Evaluation (AGREE II) instrument to 
compile the guidelines.[11]
Key questions related to current principles and practice regarding 
death certification were drafted by the meeting steering committee. 
During three rounds of a modified Delphi process[12] using 
Surveymonkey (SVMK Inc., USA), a web-based application, the 
expert panel progressively modified, deleted or added questions 
and components. Participants were asked to rate agreement with 
each component between 1 and 9 on a Likert scale, with 1 - 3 being 
‘not important’, 3 - 6 being ‘important but not critical’ and 7 - 9 being 
‘critically important’, or state if they were unable to comment. This scale 
is recommended by the Grading of Recommendations Assessment, 
Development and Evaluation working group.[11,13] Participants were 
invited to suggest additional questions for consideration for the round 
table in each round using free-text responses. Although five to 10 
experts are considered adequate for content validation, we used 18 to 
ensure a broadly representative group.[14]
Precise terminology was reviewed and finalised in order to improve 
clarity in death determination discussions and debate. We defined 
consensus for the Delphi a priori based on guidance in The COMET 
Handbook.[15] For inclusion in the consensus outcome statement (COS), 
outcomes required at least 70% of participants in each stakeholder 
group to score the outcome as critically important and <15% to score 
the outcome as not important. Outcomes excluded from the COS 
required at least 70% of participants in each stakeholder group to 
score the outcome as not important and <15% to score the outcome 
as ‘critical’. If outcomes did not meet either criterion, they were 
presented at the round-table for discussion. The expert panel members 
summarised the responses and the available evidence and formulated 
draft recommendations that were presented and discussed at a face-
to-face round table meeting prior to the CCSSA national conference 
in Cape Town, SA, in 2019. The results were presented at a plenary 
meeting of the conference.
All questions and feedback from this meeting were then reviewed 
with the steering committee. The combined consensus statement 
and proposed guideline were circulated to all society members for 
comment over three months. All expert panel members approved the 
final document for publication. The guidelines were then submitted for 
external review and endorsement by other South African professional 
medical societies (Table 1).
Updating of the guidelines
A review period of five years was set after publication of this 
document, the review to be undertaken by the guideline development 
group of the CCSSA, unless an earlier revision is mandated by 
emerging high-quality medical evidence or legislative changes.
South African guidelines on the 
determination of death
1. General statements
Death is the clinical point of irreversible loss of the capacity for 
consciousness and the irreversible loss of the capacity to breathe.[16]
Death is determined by either neurological or circulatory criteria 
and must be made in accordance with accepted medical standards.[1]
Table 1. List of endorsing societies
Trauma Society of Southern Africa
The Association of Surgeons of South Africa
Radiology Society of South Africa
Southern African Transplantation Society
Islamic Medical Association
South African Medical Association
Resuscitation Council of South Africa
South African Thoracic Society
Colleges of Medicine of South Africa - Committee of Critical Care
Neurological Association of South Africa
Society of Neurosurgeons of South Africa
South African Paediatric Association (Affirmation of Value)
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A correctly performed clinical examination can determine the point 
of death with complete certainty. It is not necessary to wait for 
pathognomonic signs of death (hypostasis, rigor mortis, decay) to be 
present in the healthcare setting.[16,17]
In cases where there are confounders affecting the clinical 
examination, testing should be deferred until such confounders are 
resolved or ancillary testing confirms the diagnosis of death.[17]
2. Definitions
Ancillary test: an additional test that can assist with the clinical 
diagnosis of brain death.[18]
Accommodation: a period of somatic support to allow for family to 
process the diagnosis of death.
Brain death/death by neurological criteria: the preferred term 
when death is determined on neurological grounds. (This is in 
preference to the term brain-stem death and is in alignment with 
the latest guidelines.)[5]
Circulatory death/death by circulatory criteria: the preferred 
term when death is determined on circulatory grounds. (This is in 
preference to terms such as cardiac or cardiorespiratory death and 
is in alignment with the latest guidelines.)[1]
Coma: the absence of wakefulness, awareness and the capacity 
for sensory perception and responsiveness to the external 
environment.[1]
Confounder: a situation during which a diagnostic test may be 
unreliable. Repeat testing when the confounder is no longer present, 
or ancillary testing, is required to diagnose death in these settings.
Somatic support: management to support the body and organs, 
excluding the brain, after brain death has been confirmed.
3. Brain death
3.1 Preconditions for brain death testing
There must be an established aetiology compatible with complete and 
irreversible loss of all brain function prior to commencement of the 
determination of brain death.
Preconditions for brain-death testing to be valid are:
• a minimum temperature of 36°C[2,5]
• a systolic blood pressure (BP) ≥100 mmHg or a mean arterial pressure 
(MAP) ≥60 mmHg (or age-appropriate haemodynamic targets in the 
paediatric population)
• exclusion of the influence of central nervous system (CNS) depressing 
drugs. This is done by at least one of the following:
 ¡ allowing five elimination half-lives of the drug to pass before 
making an evaluation of brain death (taking into consideration the 
dose and the elimination half-life, which may be influenced by age, 
organ dysfunction or prior hypothermia)[5]
 ¡ administering an appropriate drug antagonist
 ¡ measuring drug levels[5]
 ¡ performing ancillary testing in addition to a complete clinical 
examination if there is concern about prolonged or unknown drug 
elimination
• intact neuromuscular function
 ¡ If doubt exists regarding the effects of pharmacological paralysis, a 
train-of-four nerve stimulator can be used. A normal response to 
stimulation should be observed.[3]
• correction of severe metabolic, acid-base and endocrine derangements 
that could affect the examination
 ¡ If these derangements cannot be corrected and are judged to be 
potentially contributing to the loss of brain function, ancillary 
testing must be used after a clinical examination of brain death has 
been completed.
3.1.1 Additional remarks: Preconditioning[5]
Neuroimaging is recommended when available to assist with establishing 
an aetiology and confirming brain injury.
Neuroimaging is not required for the diagnosis of brain death where 
an obvious cause is known.
Drug levels should not exceed the therapeutic range and, if within 
a therapeutic range, not be associated with an altered level of 
consciousness.
Barbiturates have long and variable elimination half-lives, so blood 
levels should be measured and documented to be below that of clinically 
significant effects (<10 mg/L) or alternatively ancillary testing should be 
used to diagnose brain death.
If there is concern about severe alcohol intoxication being the 
primary cause of coma, the blood alcohol level should be shown to be 
<80 mg/dL.
Consensus was not achieved on a standardised observation period 
prior to brain-death testing. The appropriate observation period was 
felt to be specific to each individual case. However:
• in cases of anoxic brain injury, this observation period should be 
24 hours
• in cases where therapeutic hypothermia was used, there should 
be a 24-hour period of normothermia prior to an examination for 
brain death
• in paediatrics, a cautious approach is advised, given the frequent 
presence of confounders in this group.
It must be possible to adequately examine the brain-stem reflexes. 
It must be possible to examine at least one eye and one ear and safely 
perform apnoea testing.[3,5]
Apnoea testing may be precluded by severe hypoxic respiratory failure 
or a high cervical cord injury, in which case ancillary testing can be used 
after confirming that brain-stem reflexes are absent.[3,5]
While trying to provide broad guidance on the magnitude of metabolic 
and endocrine disorders which are likely to influence the testing of brain-
stem reflexes, it is essential to bear in mind that the most important 
factor is the establishment of an unequivocal cause for the individual’s 
coma.[17]
It is recognised that circulatory, metabolic and endocrine disturbances 
(e.g. hypotension, hypernatraemia, diabetes insipidus) are likely 
accompaniments of death as a result of cessation of brain-stem function. 
It is important to emphasise that these may be the effect rather than the 
cause of cessation of brain function and do not preclude the diagnosis of 
death by neurological testing.[17]
It is recognised that:[17]
• Sodium can cause unresponsiveness at levels <115 or >160 mmol/L.
• Serum potassium levels can cause flaccid paralysis below 1 mmol/L. 
Therefore, we recommend a level >3 mmol/L be confirmed.
• Profound elevation or lowering of phosphate or magnesium can be 
associated with severe neuromuscular weakness at levels <0.5 or >3.0 
mmol/L and may need to be corrected.
• Hyperglycaemia in diabetic ketoacidosis or hyperosmolar non-ketotic 
coma may cause a state of unresponsiveness which mimics irreversible 
cessation of brain-stem function, but this state is extremely unlikely 
with blood glucose levels <20 mmol/L.
• Severe hypoglycaemia is associated with coma or stupor and 
testing of brain-stem reflexes should not be undertaken if the 
glucose level is <4 mmol/L. As blood glucose concentrations 
change rapidly in critically ill patients, a blood glucose 
measurement should always be made immediately prior to the 
testing of brain-stem reflexes.
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The following endocrine conditions are extremely rare and unlikely 
to co-exist in the presence of known primary pathologies. If there is 
any clinical reason to expect these disturbances, then it is obligatory 
to ensure appropriate hormonal assays are undertaken.
• Myxoedema may cause a deep unresponsive coma.
• An Addisonian crisis may be associated with severe neuromuscular 
weakness, causing an acute ascending paralysis or encephalopathy 
proceeding to coma.
3.2 Braindeath testing[3,5,17] 
The testing process comprises assessment for:
1. coma
2. absence of brain-stem reflexes
3. inability to breathe.
A detailed explanation of the testing process is outlined 
(Table 2).
Table 2. Clinical testing for brain death – coma, brain stem reflexes, apnoea test
Clinical testing for Test and interpretation Cautionary remarks
1. Coma Test: Assess both centrally and peripherally. Apply 
deep pressure to all of the following:
• the condyles at the level of the temporomandibular 
joints
• the supra-orbital notch bilaterally
• the sternal notch
• all four extremities, via deep nail bed pressure.
Interpretation: Noxious stimuli should not produce 
grimacing, facial muscle movement or a motor 
response of the limbs other than spinally mediated 
reflexes.  Any non-spinal reflex response is 
incompatible with a brain death diagnosis. 
A multilevel assessment of motor function is important 
to exclude focal lesions. The clinical differentiation of 
spinal responses from brain-mediated motor responses 
requires expertise. Consultation with an experienced 
practitioner is recommended if the origin of a response 
is unclear. Alternatively, if interpretation is unclear, 
ancillary testing is recommended.
2. Brain-stem reflexes Testing of the brain-stem reflexes comprises examination of the cranial nerves: pupils, ocular movements, facial 
sensation and movement, pharyngeal and tracheal response. These are tested sequentially and bilaterally when 
possible. All brain-stem reflexes must be absent to determine brain death.
2.1. Pupillary light reflex – 
cranial nerves II and III
Test: Shine a bright light into the eye and look for a 
pupillary constrictor response.
Interpretation: There should be no pupillary response.
The pupils should not be pinpoint. Pupils do not 
have to be fully dilated. Anticholinergic drugs such as 
atropine can cause pupillary dilatation. Cataract or iris 
surgery is not a contraindication to clinical testing.
2.2. Corneal reflex – cranial 
nerves V and VII
Test: Touch the corneas with soft cotton wool or gauze 
and examine the eyes for blinking or a withdrawal 
response.
Interpretation: No blinking or withdrawal response.
Touching the sclera is not sufficient. Remove contact 
lenses. Examine the cornea gently as it is easily 
damaged.
2.3. Response to pain in the 
trigeminal distribution – 
cranial nerves V and VII
Test: Apply pain over the trigeminal distribution 
with deep pressure over the supra-orbital nerve 
bilaterally and to the condyles at the level of the 
temporomandibular joints.
Interpretation: No grimacing, facial muscle movement 
or motor response of the limbs other than spinally 
mediated reflexes.
In patients with spinal cord injuries, peripheral 
sensation and motor function can be lost and it is 
essential to adequately assess response to stimuli 
through brainstem-mediated sensation and motor 
response.
2.4. Vestibulo-ocular reflex – 
cranial nerves III, IV, VI and 
VIII
Test (cold caloric): Inspect the external auditory 
canal with an otoscope to confirm that the eardrum 
is visible. If the eardrum is not visible, the canal must 
be cleared before testing can occur. Elevate the head 
to 30° to align the semi-circular canal and generate 
a maximal response. Flush 50 mL of ice-cold water 
into the ear canal using a syringe. Hold eyelids open 
and observe for eye movement for a minimum of 60 
seconds.
Interpretation: No eye movement in response to the 
cold water; the eyes remain in the midline within the 
socket.
Presence of a ruptured eardrum does not invalidate 
the test. Fractures to base of skull or petrous temporal 
bone may obliterate the response on the side of the 
fracture. Testing should not proceed on that side if 
there is cerebrospinal fluid (CSF), blood or brain tissue 
in the external auditory canal.
Vestibulo-ocular reflex – 
cranial nerves III, IV, VI and 
VIII
Not required/recommended: Testing for the oculo-
cephalic (head turning/doll’s eye) reflex examines the 
same reflex pathways as cold caloric testing but is a sub-
maximal stimulus and is not recommended. It may also 
aggravate a pre-existing cervical spinal injury.
...continued
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Table 2. (continued) Clinical testing for brain death – coma, brain stem reflexes, apnoea test
Clinical testing for Test and interpretation Cautionary remarks
2.5. Gag reflex – cranial nerves 
IX and X
Test: Stimulate the posterior pharyngeal wall, on both 
sides, with a tongue depressor or Yankauer suction.
Interpretation: No gag response seen.
2.6. Cough reflex – cranial 
nerve X
Test: Stimulate the tracheobronchial wall with a soft 
suction catheter.
Interpretation: No cough response seen.
The efferent limbs for this reflex are the phrenic 
nerve and the innervation of the thoracic and 
abdominal musculature. Therefore, it cannot be 
assessed in patients with a complete high cervical 
injury.[21] 
3. Apnoea test Only proceed with the apnoea test if all above reflexes are absent. Apnoeic oxygenation is used to 
demonstrate lack of ventilatory drive. This involves the supply of 100% oxygen to the trachea, without 
providing ventilatory assistance. Through mass-movement, oxygen reaches the alveoli, allowing for 
transfer to the blood. In the absence of ventilation, paCO2 rises and stimulates the brain-stem respiratory 
centres, causing spontaneous breathing. As the paCO2 rises, the ventilatory centre is maximally stimulated 
by a paCO2 >60 mmHg (8 kPa) and pH <7.30. An attempt at breathing is defined as any respiratory muscle 
activity that results in abdominal or chest excursions or activity of accessory respiratory muscles.
Test: Pre-oxygenate the patient with 100% oxygen 
for 10 minutes to allow for elimination of nitrogen 
and to prevent hypoxaemia during the test. Perform 
a baseline blood gas measurement. Disconnect 
the patient from the mechanical ventilator. Supply 
continuous oxygen via a T-piece (preferred) or 
through a catheter inserted through the endotracheal 
tube and placed above the carina.
Observe continuously for any spontaneous breathing.
At the end of the period without mechanical 
ventilation, apnoea must persist in the presence of 
an adequate stimulus to spontaneous ventilation, i.e. 
an arterial paCO2 >60 mmHg (8 kPa) and an arterial 
pH <7.30. Take an arterial blood gas to document 
the rise in paCO2 and change in pH.  At the end of 
the test, reconnect the patient to the mechanical 
ventilator.
Interpretation: No breathing effort is seen at any 
point. Apnoea testing should be aborted if:
• spontaneous respirations are witnessed during 
apnoea testing
• systolic blood pressure becomes <100 mmHg 
or mean arterial pressure   becomes <60 mmHg 
despite titration of inotropes/vasopressors (age-
appropriate targets for paediatrics)
• there is sustained desaturation below 85%
• an unstable arrhythmia occurs.
It is suggested that prior to aborting the apnoea test 
because of cardiorespiratory instability, an arterial 
blood gas (ABG) be sent for testing. If the paCO2 
target is met, the apnoea test can be considered 
positive (consistent with brain death).
Throughout the procedure, monitor the patient’s 
SpO2.
An option to minimise the time required for the 
paCO2 to rise to the desired level, is to adjust the 
minute ventilation to mild hypercarbia (paCO2 ~45 
mmHg (6 kPa)) before disconnecting the patient 
from the ventilator.
If using a catheter, supply oxygen at 4 - 6 L/min. 
The diameter of the catheter must be <70% of the 
diameter of the endotracheal tube. When using the 
tracheal insufflation method, care should be taken to 
avoid high oxygen flows and wedging of the catheter 
insufflating oxygen as high intrapulmonary airway 
pressure may cause barotrauma.
The period of observation to achieve an adequate 
threshold of stimulus of the respiratory centre is 
variable. Usually paCO2 rises by ~3 mm Hg (0.4 kPa) 
for every minute of apnoea.
If starting from normocapnia, the paCO2 is likely to 
be >60 mmHg (8 kPa) after 10 minutes. If this is not 
the case at 10 minutes and the patient is stable, wait a 
further 5 minutes and repeat the arterial blood gas.
In patients with pre-existing hypercapnia, it is 
recommended to wait for a paCO2 rise >20 mmHg 
(2.7 kPa) above the chronic level, with a pH <7.30.
Failure of the paCO2 to rise is most likely due to an 
inappropriately high oxygen flow rate via a tracheal 
catheter.
If hypoxia occurs, 1 - 2 positive pressure breaths can 
be given, and apnoea testing continued.
Adequate pre-oxygenation and recruitment usually 
avoids this problem.
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Two doctors are required to confirm the diagnosis of brain death. 
One of the doctors must have more than five years’ experience (since 
qualification as a medical practitioner). Neither doctor must be 
involved with a transplantation team.[19]
Two doctors should perform the brain death testing together. If 
testing is done separately, there is no need for a delay between the 
tests; however, it is strongly advised that a single apnoea test should 
be done by the two doctors together.[5,20]
3.2.1 Additional remarks: Apnoea testing
We do not recommend using a spontaneous breathing mode and 
remaining connected to the ventilator during apnoea testing. 
Performing testing in such a manner typically requires turning 
off the ventilator’s default safety features to prevent back-up 
apnoea ventilation. If a patient remains connected to a mechanical 
ventilator, auto-triggering can give a false impression that a person 
is breathing spontaneously. This occurs when the ventilator is set 
on a spontaneous breathing mode (pressure support ventilation) 
and either extrinsic or intrinsic factors generate sufficient change 
in airflow or negative pressure that exceeds the trigger threshold, 
leading to a mechanically delivered breath. Extrinsic causes for 
auto-triggering include excessive condensation in ventilator tubing, 
endotracheal tube leak, chest tubes, and random artefacts or noise 
in the ventilator circuit, while intrinsic causes include cardiogenic 
oscillation, especially in a hyperdynamic cardiovascular state.[5]
3.2.2 Additional remarks: Clinical observations
Observations compatible with a diagnosis of brain death are:[3]
• spinal reflexes (which can be spontaneous or elicited by 
stimulation)[22,23]
 ¡ extension-pronation movements of the upper limbs
 ¡ nonspecific flexion of the lower limbs
 ¡ presence of deep tendon reflexes
 ¡ plantar responses, either flexor or extensor
 ¡ respiratory-like movements (shoulder elevation and adduction, 
back arching or intercostal expansion) without significant tidal 
volume
 ¡ undulating toe reflex (plantar flexion of great toe, followed by 
brief plantar flexion sequentially of second to fifth toes)
 ¡ Lazarus sign (bilateral arm flexion, shoulder adduction, hand 
raising to above the chest, and may include flexion of trunk, hips 
and knees)
 ¡ head turning
• sweating, blushing, tachycardia
• normal blood pressure without the need for pharmacological 
support
• absence of diabetes insipidus (DI) (preserved osmolar control 
mechanism).
Observations incompatible with brain death are:
• decerebrate or decorticate posturing
• true extensor or flexor motor responses to painful stimuli
• witnessed seizures.
3.3 Ancillary testing
The clinical exam is considered the most sophisticated way of testing 
neurological function in that it deliberately delivers a stimulus to 
provoke central processing followed by an efferent response. All 
ancillary tests infer the integrity of this stimulus-integration-response 
arc, but do not observe it directly.[5]
It is recommended that the clinical exam be completed to the fullest 
extent possible prior to conducting an ancillary test.[5]
Making an appropriate choice of an ancillary test depends on the 
clinician and the clinical circumstances. The most effective method 
to address a confounder must be identified using an educated 
appraisal of the strengths and weaknesses of those tests that are 
readily available.[5]
It is recommended that ancillary testing is required in the 
following circumstances:[5]
• inability to complete a clinical neurological determination of death, 
including the apnoea test
• confounding conditions  which would invalidate clinical testing that 
cannot be resolved
• uncertainty regarding interpretation of spinal-mediated motor reflexes
• pre-existing severe neuromuscular disorder, such as amyotrophic 
lateral sclerosis or a pre-existing severe sensory neuropathy.[24,25]
Ancillary testing which establishes the absence of intracranial blood 
flow is the preferred method of testing where available.[5]
• radionuclide studies
• conventional four-vessel cerebral angiography
• transcranial Doppler.
It is suggested that electrophysiological testing with an 
electroencephalogram (EEG) not be utilised routinely as an ancillary 
test, given its low specificity.[5,26] EEG testing may, however, be 
preferred where craniovascular impedance has been affected by 
an open skull fracture, decompressive craniectomy, or an open 
fontanelle/suture in infants.[5,27]
It is suggested that computed tomography angiography (CTA) 
and magnetic resonance angiography (MRA) which may be used 
in the investigation of these patients not be used in isolation 
to support a diagnosis of cerebro-circulatory arrest at present, 
pending further research into the sensitivity and specificity of 
these modalities.[5,28-35]
3.3.1 Technical aspects of ancillary testing
Radionuclide/brain scintigraphy studies
To confirm brain death with radionuclide/scintigraphic techniques, 
the study must demonstrate absence of intracranial isotope.[5,36-38]
• Diffusible radiopharmaceuticals (brain-specific tracers) should be 
used preferentially.
• Single photon emission computed tomography (SPECT) is 
preferred over planar imaging.
• If SPECT is not available, perfusion scintigraphy with anterior 
and lateral planar imaging should be used with appropriate time 
intervals to demonstrate static filling of the posterior fossa.
Cerebral angiography
If used as an ancillary test to confirm brain death, four-vessel cerebral 
angiography must demonstrate absent filling at the points where 
the internal carotid and vertebral arteries enter the skull base, with 
demonstration of patent external carotid circulation.[39]
Transcranial doppler
Transcranial doppler testing is operator training dependent, needs 
specialised probes and requires that:[40,41]
• two examinations be performed ≥30 minutes apart
• the examinations be performed bilaterally, anteriorly and 
posteriorly to include both internal carotid arteries as well as the 
vertebrobasilar circulation
• the exams illustrate biphasic oscillating flow and systolic spikes 
with reversal of flow in diastole in order to make a declaration of 
brain death.
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Transcranial doppler testing is not validated in paediatrics[42] and is 
not widely available in SA.
Electroencephalography (EEG)
If EEG testing is used, it should be used in conjunction with 
somatosensory and brainstem auditory evoked potentials.[43]
EEG should be interpreted as demonstrating absence of brain 
activity when a 30-minute study is isoelectric above 2 microvolts 
with a sensitivity of 2 microvolts/mm and filter of 0.1 or 0.3 seconds 
and 70 Hz.[5,44]
3.4 Paediatric considerations in brain death
A cautious approach with a low threshold for serial examinations is 
recommended in this population group.[5,45]
Brain death cannot be diagnosed in neonates <36 weeks’ corrected 
gestation.[3,4]
Clinical assessment of brain death in neonates and the 
paediatric population is the same as in adults, with age-appropriate 
haemodynamic targets,[46,47] except that in neonates (<4 weeks) the 
sucking and rooting reflex should be absent in addition to the other 
brain-stem reflexes.[5]
Ancillary testing (as with adults) is not routinely required in this 
population group when clinical testing confirms brain death.[45]
A T-piece should be used for oxygenation during the apnoea test in 
paediatric patients in preference to the tracheal insufflation method, 
owing to the risk of barotrauma with this method.[5]
In patients with chronic hypoxaemia owing to cyanotic heart disease, 
apnoea testing should not be performed and instead an ancillary study 
be conducted to assist with the determination of brain death.[5]
3.5 ECMO and brain death[48-50]
The same fundamental principles of brain-death testing apply to 
patients on extracorporeal membrane oxygenation (ECMO).
The apnoea test should be performed in patients on veno-arterial 
(VA) or veno-venous (VV) ECMO unless unable to be completed 
owing to haemodynamic instability.
In VA ECMO, the flow rate may be adjusted to maintain a MAP 
≥60 mmHg during testing.
Preoxygenation prior to apnoea testing should be done by 
increasing the inspired oxygen via the mechanical ventilator to 100% 
and to the membrane lung of the ECMO machine to 100% for 10 
minutes. The sweep gas flow should be titrated to <1 L/min while 
maintaining oxygenation in order to allow a rise in carbon dioxide 
(CO2). Apnoea must persist in the presence of an adequate stimulus 
to spontaneous ventilation, i.e. an arterial paCO2 >60 mmHg (8 kPa) 
or 20 mmHg above the patient’s baseline and an arterial pH <7.30. 
Serial blood gases may be required as achieving the rise in CO2 may 
take longer to achieve than in a person without ECMO support.
3.6 Pregnancy and brain death[51-54]
If a decision is made to offer somatic support to a brain-dead 
pregnant patient, it is recommended that a multidisciplinary team 
of intensivists, obstetricians, social workers, psychologists and 
neonatologists be involved.
The consent to continue providing somatic support to a brain-
dead pregnant patient should be made in keeping with the HPCSA 
professional rules on consent.[55] Due consideration to duration 
of support required, the high-risk nature of the delivery and an 
assessment of the home and legal circumstances needs to be 
conducted by a multidisciplinary team.
The fetus should be routinely monitored with at least daily heart 
rate checks, given that fetal health may affect decision-making.
Antenatal steroids should be administered to facilitate fetal lung 
maturation with preparations for delivery made between 26 and 33 
weeks when fetal lung maturity is reached.
3.7 Family accommodation in brain death
While it is reasonable to provide accommodation for a finite period 
of time, assuming that the specific timeframe for doing so is brief, 
that resources allow, and that a family is informed of the timeframe 
in advance, accommodation ordinarily should not be provided for a 
period greater than 24 hours.
It is ethically and legally appropriate for the treating team to end 
somatic support for a body when the family has been adequately 
counselled on the diagnosis of death and the option of organ 
donation explored.
An additional clinician in the hospital can provide the family with 
a second opinion regarding determination of brain death if it is felt 
that this may assist the family in accepting the person’s death.
Even in the setting of requests for accommodation, support should be 
discontinued if a person has been declared brain-dead and the hospital 
bed is required for a living patient where no other bed is available.[5]
4. Circulatory death
4.1 Preconditions for circulatory death testing
To declare death on circulatory grounds, one of the following 
criteria must be met:
• it is inappropriate to attempt cardiopulmonary resuscitation
• attempts at cardiopulmonary resuscitation have failed
• treatment aimed at sustaining life has been withdrawn.
Treatment may be withdrawn because:[56]
• it has been assessed to be of no further benefit to the patient (non-
beneficial/futile) and is not in his or her best interest to continue
• it is in respect of the patient's wishes via an advanced directive to 
refuse life-sustaining treatment
• it is in respect of the patient’s wishes as expressed by their legal 
surrogate decision-maker.
4.2 Circulatory death testing
The patient should be observed by the person responsible for 
confirming death for a minimum period of five minutes to establish 
that irreversible circulatory arrest has occurred.[57]
The absence of mechanical cardiac function should be confirmed 
using a combination of the following:
• absence of a central pulse on palpation
• absence of heart sounds on auscultation.
In the hospital setting, clinical assessment of absent mechanical 
cardiac function can be supplemented by one or more of the 
following:
• absence of pulsatile flow using direct intra-arterial pressure 
monitoring
• absence of contractile activity using echocardiography.
Once mechanical cardiac function is confirmed as absent by clinical 
assessment, intra-arterial pressure monitoring or echocardiography, 
the 5-minute waiting period can begin.
Any spontaneous return of circulatory or respiratory activity 
during the five-minute observation period should prompt a reset of 
the observation period from this point.[58]
Spontaneous return of circulatory or respiratory activity is not an 
indication to begin resuscitation efforts in a context where this has 
been determined to be inappropriate.
GUIDELINE
374   /SAJCC     April 2021, Vol. 111, No. 4 (Part 2)
After the 5-minute period of continued circulatory arrest has passed, 
the absence of pupillary responses to light and of any motor response 
to supra-orbital pressure should be confirmed.[59-61] The time of death is 
recorded as the time at which these criteria are fulfilled.[1]
It is inappropriate to initiate any intervention that has the potential 
to restore cerebral perfusion after death has been confirmed.[3,62]In 
cases where organ donation after circulatory death takes place, a 
second doctor is required to certify the death.[19]
5. Organ donation
End-of-life care should, as standard of care, explore the patient's 
wishes regarding organ and tissue donation.[63]
The recommended time for a clinical assessment of organ donation 
potential (with the transplant co-ordinator) is when the treating 
team makes a decision to perform brain-death testing or to initiate 
discussions with the family to withdraw life-sustaining treatment. 
This allows clarification of the potential for organ and tissue donation 
prior to end-of-life discussions, and an informed approach for 
consent from the family.[64]
Somatic support of a brain-dead patient is appropriate to allow the 
possibility of organ and tissue donation to be fully explored with the 
family.[3]
6. Training and documentation
All doctors should be trained in the determination of death. It 
is recommended that a standardised checklist be used for death 
determination and its documentation.[65,66]
Consultation with a medical practitioner experienced in the 
diagnosis of brain-death is advised in situations where the diagnosis 
and testing are uncertain.
All doctors training in disciplines that manage patients with severe 
brain injuries should receive detailed training in the preconditions for 
brain-death testing, clinical testing procedures, indications for and 
utility of ancillary testing, somatic support of the brain-dead patient, 
and techniques for effective counselling of  families.[5,65,67]
All phases of the brain death determination should be documented 
in the medical record, including:[5,68]
• aetiology of the coma
• absence of confounders
• full details of the clinical testing performed, including apnoea 
testing and laboratory values
• neuroimaging results if done
• the reason for ancillary testing if performed and the findings
• time and date of death
• identity of the practitioners performing the evaluation, with their 
HPCSA numbers.
In cases where brain death can be determined with a neurological 
exam and ancillary testing is not needed, the time of death must be 
documented as the time the arterial paCO2 reaches the target, with 
no spontaneous respirations seen, during the apnoea test confirmed 
by two doctors.[3,5]
In cases where the doctors were not able to complete the apnoea 
test together, the time of death will be upon completion of the second 
apnoea test.[3,5]
In cases where ancillary testing is performed, the time of death 
must be documented as the time that the ancillary test results are 
formally interpreted and documented.[3,5]
Determination of death on the basis of circulatory criteria should be 
documented in the medical record, including:
• in cases where resuscitation was attempted, a record of the 
resuscitation attempts and the time resuscitation was stopped
• in cases where resuscitation was not attempted, the rationale
• confirmation of absent pupillary and pain response, respiratory 
effort and circulation after a 5-minute period
• time and date of death
• identity of the practitioner/s performing the evaluation, with their 
HPCSA number/s.
7. Strengths and limitations
This guidance document offers clear, pragmatic evidence-based medical 
guidance in the determination of death in the SA context. The provided 
checklists (Figs 1 - 4) offer a summary of the recommendations for 
clinical application. A limitation of this document is that a lack of 
high-quality data from large randomised clinical trials prevented the 
use of formal analytical techniques (GRADE, AGREE) in the literature 
appraisal. It is also acknowledged that these recommendations were 
developed without direct patient, cultural and religious input; however, 
the panel of experts did represent a broad range of cultural and 
religious viewpoints from across SA.
7.1 Applicability, barriers, facilitators and cost 
implications of these guidelines
Barriers to effective implementation of death determination 
guidelines include a lack of uptake and acceptance by both clinicians 
and the public as well as the challenge of ensuring cultural and 
religious engagement and support for the medical determination 
of death. The endorsement and application of these guidelines 
is to be formally encouraged across all healthcare disciplines. 
Undergraduate and postgraduate teaching should consider these 
guidelines as the standard of care for the determination of death in 
SA and incorporate them into their training programmes. Hospital 
policies and standard operating procedures should similarly align 
themselves with the guidelines to prevent differing practices 
across institutions, which can cause confusion among clinicians, 
families and the general public.[9,69] Use of the provided checklists 
is expressly recommended in the guidelines to facilitate clinicians 
to apply them in their daily practice. Continuing professional 
development programmes should incorporate these guidelines in 
the education of practising clinicians.
Pursuing a diagnosis of brain death may entail additional 
resources, and the clinician must judge the appropriateness in each 
clinical context. The beneficial effects of organ and tissue donation 
to the SA public and healthcare system are large. Exploring the 
option of organ and tissue donation at the end of life is a standard 
of care that should be fully assessed and appropriately explored 
with all patients and their families. Folder reviews and audits 
of documentation completed at end of life to assess compliance 
with these guidelines will assist in improving standards in death 
determination and end-of-life care.[70]
8. Conclusion
Death can be determined with complete certainty by medical 
professionals adhering to these guidelines which offer the clinician 
the latest evidence in best practice for determining death by either 
neurological or circulatory criteria. Use of the attached checklists is 
recommended.
Acknowledgements. The Critical Care Society of Southern Africa for 
facilitating the creation of these guidelines.
Author contributions. DT led the consensus process, developed and 
supervised the methodology, and chaired the face-to-face round-table 
meeting; was responsible for initial literature search, drafting of consensus 
GUIDELINE
375   /SAJCC     April 2021, Vol. 111, No. 4 (Part 2)
key questions and supervised the Delphi process, including the drafting 
and grading of recommendations; drafted the manuscript, supervised 
revisions to the drafts, and approved the final manuscript.
IJ, DG, FP, KDV chose the participants, developed and supervised the 
methodology, participated in the Delphi process and face-to-face round-
table meeting, performed literature searches, participated in manuscript 
drafting and revisions to the drafts, and approved the final manuscript.
SM, RM, MM, BM, DB, BR, NM, GAR, NW, BL, MS, NA participated 
in the Delphi process and face-to-face round-table meeting, drafted and 
graded associated recommendations; participated in revisions to the 
drafts and approved the final manuscript.
IC participated in the Delphi process, drafted and graded associated 
recommendations; participated in revisions to the drafts and approved the 
final manuscript.
Funding. These guidelines were internally funded by the Critical Care 
Society of Southern Africa (CCSSA), a registered non-profit organisation 
dedicated to delivering appropriate, quality care to the critically ill. 
The authors declare that the views or interests of the CCSSA have not 
influenced the final recommendations.
Conflicts of interest. All authors declare that there were no potential 
conflicts of interest.
1. World Health Organization. Clinical criteria for the determination of death, WHO technical expert 
consultation, WHO Headquarters, Geneva, Switzerland, 22 - 23 September 2014. Geneva: WHO; 2017. 
https://apps.who.int/iris/bitstream/handle/10665/254737/WHO-HIS-SDS-2017.5-eng.pdf;jsessionid=D
BBFDE5645ED697AEA0D373772F54BDF?sequence=1 (accessed 4 August 2020).
2. Wijdicks EF, Varelas PN, Gronseth GS, Greer DM. Evidence-based guideline update: Determining brain 
death in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology. 
Neurology 2010;74(23):1911-1918. https://doi.org/10.1212%2Fwnl.0b013e3181e242a8
3. Australian Society NZIC. The ANZICS statement on death and organ donation: Australian and New 
Zealand Intensive Care Society, 2008. https://csds.qld.edu.au/sdc/Provectus/ELI/Module%202%20-%20
Organ%20donation%20after%20brain%20death/files/ANZICS%20Statement%20on%20%20Death%20
and%20Organ%20Donation%20Edition%203.2%20(3).pdf (accessed 4 August 2020).
4. Shemie SD, Doig C, Dickens B, et al. Severe brain injury to neurological determination of 
death: Canadian forum recommendations. Canadian Med Ass J 2006;174(6):S1-13. https://doi.
org/10.1503%2Fcmaj.045142
5. Greer DM, Shemie SD, Lewis A, et al. Determination of brain death/death by neurologic criteria: The 
World Brain Death Project. JAMA 2020;324(11):1078-1097. https://doi:10.1001/jama.2020.11586
6. Wahlster S, Wijdicks EF, Patel PV, et al. Brain death declaration: Practices and perceptions worldwide. 
Neurology 2015;84(18):1870-1879. https://doi.org/10.1212%2Fwnl.0000000000001540
7. Chang MY, McBride LA, Ferguson MA. Variability in brain death declaration practices in pediatric head 
trauma patients. Pedia Neuro 2003;39(1):7-9. https://doi.org/10.1159%2F000070871
8. Citerio G, Crippa IA, Bronco A, Vargiolu A, Smith M. Variability in brain death determination in Europe: 
Looking for a solution. Neurocrit Care 2014;21(3):376-382. https://doi.org/10.1007%2Fs12028-014-9983-x
9. Greer DM, Varelas PN, Haque S, Wijdicks EF. Variability of brain death determination guidelines in 
leading US neurologic institutions. Neurology 2008;70(4):284-289. https://doi.org/10.1212%2F01.
wnl.0000296278.59487.c2
10. Wijdicks EFM. Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. 
Neurology 2002;58(1):20-25.  https://doi.org/10.1212%2Fwnl.58.1.20
11. Brouwers MC, Kerkvliet K, Spithoff K, Consortium ANS. The AGREE Reporting Checklist: A tool to 
improve reporting of clinical practice guidelines. BMJ 2016;352:i1152. https://doi.org/10.1136%2Fbmj.i1152
12. Dalkey N, Helmer O. An experimental application of the Delphi method to the use of experts. Manag Sci 
1963;9(3):458-467. https://doi.org/10.1287%2Fmnsc.9.3.458
13. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: Advancing guideline development, 
reporting and evaluation in health care. Canadian Med Ass J 2010;182(18):E839-E842. https://doi.
org/10.1503%2Fcmaj.090449
14. Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: Application of bootstrap 
data expansion. BMC Med Res Method 2005;5(1):37. https://doi.org/10.1186%2F1471-2288-5-37
15. Williamson PR, Altman DG, Bagley H, et al. The COMET handbook: Version 1.0. Trials 2017;18(3):280. 
https://doi.org/10.1186%2Fs13063-017-1978-4
16. Gardiner D, Shemie S, Manara A, Opdam H. International perspective on the diagnosis of death. Br J 
Anaesthesia 2012;108 Suppl 1:i14-28. https://doi.org/10.1093/bja/aer397
17. Academy of Medical Royal Colleges. A code of practice for the diagnosis and confirmation of brain death. 
London: AOMRC,2008. 
18. Busl KM, Greer DM. Pitfalls in the diagnosis of brain death. Neurocrit Care 2009;11(2):276-287. https://
doi.org/10.1007%2Fs12028-009-9231-y
19. McQuoid-Mason D. Medicine and the law. Human tissue and organ transplant provisions: Chapter 8 of 
the National Health Act and its Regulations, in effect from March 2012 – what doctors must know. S Afr 
Med J 2012;102(9):730-732. https://doi.org/10.7196%2Fsamj.6047
20. Varelas PN, Rehman M, Abdelhak T, et al. Single brain death examination is equivalent to dual brain 
death examinations. Neurocrit Care 2011;15(3):547-553. https://doi.org/10.1007%2Fs12028-011-9561-4
21. Waters C, French G, Burt M. Difficulty in brainstem death testing in the presence of high spinal cord 
injury. Br J Anaesthesia 2004;92(5):760-764. https://doi.org/10.1093%2Fbja%2Faeh117
22. Saposnik G, Basile VS, Young GB. Movements in brain death: A systematic review. Can J 
Neurol Sci [Le journal canadien des sciences neurologiques] 2009;36(2):154-160. https://doi.
org/10.1017%2Fs031716710000651x
23. Kumar A, Tummala P, Feen ES, Dhar R. Spinal decerebrate-like posturing after brain death: A 
case report and review of the literature. J Intensive Care Med 2016;31(9):622-624. https://doi.
org/10.1177%2F0885066616646076
24. Ravikumar S, Poysophon P, Poblete R, Kim-Tenser M. A case of acute motor axonal neuropathy 
mimicking brain death and review of the literature. Front Neurol 2016;7:63. https://doi.
org/10.3389%2Ffneur.2016.00063
25. Ragazzoni A, Grippo A, Tozzi F, Zaccara G. Event-related potentials in patients with total locked-in state 
due to fulminant Guillain-Barré syndrome. Int J Psychophysiol 2000;37(1):99-109. https://doi.org/10.10
16%2Fs0167-8760%2800%2900098-2
26. Paolin A, Manuali A, Di Paola F, et al. Reliability in diagnosis of brain death. Int Care Med 1995;21(8):657-
662. https://doi.org/10.1007%2Fbf01711544
27. Okuyaz C, Gucuyener K, Karabacak NI, Aydin K, Serdaroglu A, Cingi E. Tc-99m-HMPAO SPECT 
in the diagnosis of brain death in children. J Japan Pedia Soc 2004;46(6):711-714. https://doi.
org/10.1111%2Fj.1442-200x.2004.01976.x
28. Karantanas AH, Hadjigeorgiou GM, Paterakis K, Sfiras D, Komnos A. Contribution of MRI and 
MR angiography in early diagnosis of brain death. Eur Rad 2002;12(11):2710-2716. https://doi.
org/10.1007%2Fs00330-002-1336-z
29. Sohn C-H, Lee H-P, Park JB, et al. Imaging findings of brain death on 3-tesla MRI. Korean J Rad 
2012;13(5):541-549. https://doi.org/10.3348%2Fkjr.2012.13.5.541
30. Ishii K, Onuma T, Kinoshita T, Shiina G, Kameyama M, Shimosegawa Y. Brain death: MR and MR 
angiography. Am J Neuroradiology 1996;17(4):731-735.
31. Sawicki M, Sołek-Pastuszka J, Chamier-Ciemińska K, Walecka A, Walecki J, Bohatyrewicz R. Computed 
tomography perfusion is a useful adjunct to computed tomography angiography in the diagnosis of brain 
death. Clin Neuroradiology 2019;29(1):101-108. https://doi.org/10.1007%2Fs00062-017-0631-7
32. Frampas E, Videcoq M, De Kerviler E, et al. CT angiography for brain death diagnosis. Am J 
Neuroradiology 2009;30(8):1566-1570. https://doi.org/10.3174%2Fajnr.a1614
33. Garrett MP, Williamson RW, Bohl MA, Bird CR, Theodore N. Computed tomography angiography as 
a confirmatory test for the diagnosis of brain death. J Neurosurgery 2018;128(2):639-644. https://doi.
org/10.3171%2F2016.10.jns161042
34. Shankar J, Vandorpe R. CT perfusion for confirmation of brain death. Am J Neuroradiology 
2013;34(6):1175-1179. https://doi.org/10.3174%2Fajnr.a3376
35. Taylor T, Dineen RA, Gardiner DC, Buss CH, Howatson A, Pace NL. Computed tomography (CT) 
angiography for confirmation of the clinical diagnosis of brain death. Cochrane Database Syst Rev 
2014(3): CD009694. https://doi.org/10.1002%2F14651858.cd009694.pub2
36. Joffe AR, Lequier L, Cave D. Specificity of radionuclide brain blood flow testing in brain death: Case 
report and review. J Int Care Med 2010;25(1):53-64. https://doi.org/10.1177%2F0885066609355388
37. Flowers JW, Patel BR. Radionuclide angiography as a confirmatory test for brain death: a review 
of 229 studies in 219 patients. South Med J 1997;90(11):1091-1096. https://doi.org/10.1097%
2F00007611-199711000-00007
38. Donohoe KJ, Agrawal G, Frey KA, et al. SNM practice guideline for brain death scintigraphy 2.0. J Nucl 
Med Technol 2012;40(3):198-203. https://doi.org/10.2967%2Fjnmt.112.105130
39. Braun M, Ducrocq X, Huot J-C, Audibert G, Anxionnat R, Picard L. Intravenous angiography 
in brain death: Report of 140 patients. Neuroradiology 1997;39(6):400-405. https://doi.
org/10.1007%2Fs002340050432
40. Chang JJ, Tsivgoulis G, Katsanos AH, Malkoff MD, Alexandrov AV. Diagnostic accuracy of transcranial 
doppler for brain death confirmation: Systematic review and meta-analysis. Am J Neuroradiology 
2016;37(3):408-414. https://doi.org/10.3174%2Fajnr.a4548
41. Monteiro LM, Bollen CW, van Huffelen AC, Ackerstaff RG, Jansen NJ, van Vught AJ. Transcranial 
Doppler ultrasonography to confirm brain death: A meta-analysis. Int Care Med 2006;32(12):1937-1944. 
https://doi.org/10.1007%2Fs00134-006-0353-9
42. Mata-Zubillaga D, Oulego-Erroz I. Persistent cerebral blood flow by transcranial Doppler 
ultrasonography in an asphyxiated newborn meeting brain death diagnosis: Case report and review of 
the literature. J Perinatol 2012;32(6):473-475. https://doi.org/10.1038%2Fjp.2011.147
43. Guérit J-M, Amantini A, Amodio P, et al. Consensus on the use of neurophysiological tests in the intensive 
care unit (ICU): Electroencephalogram (EEG), evoked potentials (EP), and electroneuromyography 
(ENMG). Neurophysiologie Clinique/Clinical Neurophysiology 2009;39(2):71-83. https://doi.
org/10.1016%2Fj.neucli.2009.03.002
44. Wijdicks EF. Determining brain death in adults. Neurology 1995;45(5):1003-1011. https://doi.
org/10.1212%2Fwnl.45.5.1003
45. Abbott J, Kennedy C, Marshment V, Mcfadzean J, Mcintosh N, Snowdon C. Royal College of Pediatrics 
and Child Health. The diagnosis of death by neurological criteria in infants less than 2 month old. 2015. 
https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/1354/neurological-death-dnc-guide-final.
pdf. London, UK: Royal College of Paediatrics and Child Heath, 2015. 
46. Samuels M, Wieteska S, eds. Advanced Paediatric Life Support: A Practical Approach to Emergencies. 6th 
ed. USA: John Wiley & Sons, 2016:7. https://onlinelibrary.wiley.com/doi/book/10.1002/9781119241225
47. International Guidelines 2000 for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular 
Care (ECC); Part 10: Pediatric Advanced Life Support. Circulation 2000; 102(Suppl 1):291-342. https://
www.ahajournals.org/doi/epub/10.1161/circ.102.suppl_1.I-291
48. Shah V, Lazaridis C. Apnea testing on extracorporeal membrane oxygenation: Case report and literature 
review. J Crit Care 2015;30(4):784-786. https://doi.org/10.1016%2Fj.jcrc.2015.03.028
49. Smilevitch P, Lonjaret L, Fourcade O, Geeraerts T. Apnea test for brain death determination in a 
patient on extracorporeal membrane oxygenation. Neuro Care 2013;19(2):215-217. https://doi.
org/10.1007%2Fs12028-013-9845-y
50. Migliaccio M, Zagli G, Cianchi G, et al. Extracorporeal membrane oxygenation in brain-death organ 
and tissues donors: A single-centre experience. Br J Anaesthesia 2013;111(4):673-674. https://doi.
org/10.1093%2Fbja%2Faet323
51. Powner DJ, Bernstein IM. Extended somatic support for pregnant women after brain death. Crit Care 
Med 2003;31(4):1241-1249. https://doi.org/10.1097%2F01.ccm.0000059643.45027.96
52. Farragher R, Marsh B, Laffey JG. Maternal brain death – an Irish perspective. Irish J Med Sci 
2005;174(4):55-59. https://doi.org/10.1007%2Fbf03168984
53. Esmaeilzadeh M, Dictus C, Kayvanpour E, et al. One life ends, another begins: Management 
of a brain-dead pregnant mother – a systematic review. BMC Med 2010;8:74. https://doi.
org/10.1186%2F1741-7015-8-74
54. McQuoid-Mason D. Terminating the pregnancy of a brain-dead mother: Does a fetus have a right to life? 
The law in South Africa. S Afr J Bioethics Law 2014;7(2):44-46. https://doi.org/10.7196%2Fsajbl.317
55. Health Professionals Council of South Africa. Seeking patients' informed consent: The ethical con-
siderations. HPCSA; September 2016. https://www.hpcsa.co.za/Uploads/Professional_Practice/Con-
duct%20%26%20Ethics/Booklet%204%20Informed%20Consent%20September%20%202016.pdf.




57. Committee E, Medicine SoCC. Recommendations for nonheartbeating organ donation. A position 
paper by the Ethics Committee, American College of Critical Care Medicine, Society of Critical Care 
Medicine. Crit Care Med 2001;29(9):1826. https://doi.org/10.1097%2F00003246-200109000-00029
58. Sheth KN, Nutter T, Stein DM, Scalea TM, Bernat JL. Autoresuscitation after asystole in patients being 
considered for organ donation. Crit Care Med 2012;40(1):158-161. https://doi.org/10.1097%2Fccm.0
b013e31822f0b2a
GUIDELINE
376   /SAJCC     April 2021, Vol. 111, No. 4 (Part 2)
59. Hornby K, Hornby L, Shemie SD. A systematic review of autoresuscitation after cardiac arrest. Crit 
Care Med 2010;38(5):1246-1253. https://doi.org/10.1097%2Fccm.0b013e3181d8caaa
60. Clute HL, Levy WJ. Electroencephalographic changes during brief cardiac arrest in humans. 
Anesthesiology 1990;73(5):821-825. https://doi.org/10.1097%2F00000542-199011000-00004
61. Losasso TJ, Muzzi DA, Meyer FB, Sharbrough FW. Electroencephalographic monitoring of cerebral 
function during asystole and successful cardiopulmonary resuscitation. Anesth Anal 1992;75(6):1021-
1024. https://doi.org/10.1213%2F00000539-199212000-00025
62. Gardiner D, Shemie S, Manara A, Opdam H. International perspective on the diagnosis of death. Br J 
Anaest 2012;108(SUPPL 1):i14-i28. https://doi.org/10.1093%2Fbja%2Faer397
63. Domínguez-Gil B, Murphy P, Procaccio F. Ten changes that could improve organ donation in the 
intensive care unit. Intensive Care Med 2016;42(2):264-267. https://doi.org/10.1007%2Fs00134-
015-3833-y
64. Chamberlain K, Baker M, Kandaswamy P, Shaw E, McVeigh G, Siddiqui F. Donor identification and 
consent for deceased organ donation: Summary of NICE guidance. BMJ 2012;344:e341. https://doi.
org/10.1136%2Fbmj.e341
65. Shappell CN, Frank JI, Husari K, Sanchez M, Goldenberg F, Ardelt A. Practice variability in brain death 
determination: A call to action. Neurology 2013;81(23):2009-2014. https://doi.org/10.1212%2F01.
wnl.0000436938.70528.4a
66. Wang MY, Wallace P, Gruen JP. Brain death documentation: Analysis and issues. Neurosurgery 
2002;51(3):731-735. https://doi.org/10.1097%2F00006123-200209000-00021
67. Kashkoush A, Weisgerber A, Dharaneeswaran K, Agarwal N, Shutter L. Medical training and the brain 
death exam: A single institution’s experience. World Neuro 2017;108:374-378. https://doi.org/10.1016/j.
wneu.2017.08.185 
68. Wijdicks EFM, Varelas PN, Gronseth GS, Greer DM. Evidence-based guideline update: Determining 
brain death in adults: Report of the quality standards subcommittee of the American Academy of 
Neurology. Neurology 2010;74(23):1911-1918. https://doi.org/10.1212%2Fwnl.0b013e3181e242a8
69. Citerio G, Crippa IA, Bronco A, Vargiolu A, Smith M. Variability in brain death determination in Europe: 
Looking for a solution. Neuro Care 2014;21(3):376-382. https://doi.org/10.1007%2Fs12028-014-9983-x
70. Wijdicks EFM. Critical synopsis and key questions in brain death determination. Int Care Med 
2019;45(3):306-309. https://doi.org/10.1007%2Fs00134-019-05549-6
Accepted 17 November 2020.
GUIDELINE
377   /SAJCC     April 2021, Vol. 111, No. 4 (Part 2)
BRAIN DEATH CERTIFICATION 
Summary Recommendations - South African Death Determination Guidelines Checklist 
Name: Hospital Number: Date of Birth: 
Doctor 1 Doctor 2 Prerequisites 
Coma, irreversible and cause known 
Normothermia (>36°C) 
Systolic blood pressure �100 mm Hg* 
Significant metabolic, electrolyte, endocrine abnormality excluded 
Sedative/analgesic/neuromuscular drug effect excluded 
Examination** 
Pupils fixed and non-reactive 
Absent corneal reflex 
No gag reflex 
Absent cough reflex on deep suctioning down tracheal tube 
No facial grimace to supra-orbital pain 
Absence of motor response in all limbs (spinal reflexes may persist) 
Oculovestibular (cold caloric) reflex absent 
Apnoea testing – no spontaneous respiration 
Doctor 1 Doctor 2 
Name: ____________ _ Name: 
HPCSA Number: HPCSA Number: 
Signature: Signature: ___________ _ 
Date and time: Date and time: 
* or mean arterial pressure � 60 mmHg / in paediatrics age-appropriate haemodynamic targets apply 
** One doctor with more than 5 years' experience, tests may be done by both doctors simultaneously,
no doctor may be involved with the transplant team 
Fig. 1. Summary recommendations – Brain death certification checklist (https://criticalcare.org.za/resource/death-determination-checklists/).
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BRAIN DEATH CLINICAL TESTING 
Summary Recommendations - South African Death Determination Guidelines Checklist 
Apnoea test J [ ------------------------------
Apply deep pressure to: the temporomandibular joints, the supra-orbital notch 
bilaterally, the sternal notch and all four extremities via deep nail bed pressure. 
There should be no true motor response. 
Shine a bright light into the eye and look for a pupillary constrictor response. 
There should be no pupillary response. 
Touch the corneas with soft cotton wool or gauze and examine the eyes for 
blinking or a withdrawal response. 
There should be no blinking or withdrawal response. 
Apply pain over the trigeminal distribution, e.g. pressure over the supra-orbital 
nerve and to the condyles at the level of the temporomandibular joints. 
There should be no facial or limb movement. 
Stimulate the posterior pharyngeal wall, on both sides, with a tongue depressor or 
Yankauer suction. 
There should be no gag response. 
Stimulate the tracheobronchial wall with a soft suction catheter. 
There should be no cough response. 
Inspect the external auditory canal with an otoscope to confirm that the eardrum is 
visible. If the eardrum is not visible, the canal must be cleared before testing. 
Elevate the head to 30° to align the semi-circular canal and generate a maximal 
response. Flush 50 ml of ice-cold water into the ear canal using a syringe. Hold 
eyelids open and observe for eye movement for a minimum of 60 seconds. 
There should be no eye movement in response to the cold water; 
the eyes remain in the midline within the socket. 
See separate advice sheet. 
Observations that are incompatible with a diagnosis of brain death: 
Decerebrate or decorticate posturing. True extensor or flexor motor responses. Witnessed seizures. 
Observations that are compatible with a diagnosis of brain death: 
Spinal reflexes, sweating, blushing, tachycardia, and a normal blood pressure. 
Fig. 2. Summary recommendations – Brain death clinical testing (https://criticalcare.org.za/resource/death-determination-checklists/).
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APNOEA TESTING 
Summary Recommendations - South African Death Determination Checklist 
Background: 
Only proceed with the apnoea test to confirm 
brain death if all other brainstem reflexes are 
absent and patient is haemodynamically 
stable (may be on inotropes). 
Two doctors should perform a single apnoea 
test together. 
Testing procedure: 
Pre-oxygenate the patient with 100 percent 
oxygen for 10 minutes to prevent hypoxaemia 
during the test. 
Perform a baseline ABG. 
Assess baseline CO2 level (PaCO2 35 - 45 
mmHg, 4.6 - 6.0 kPa). 
Disconnect the patient from the mechanical 
ventilator and supply continuous oxygen via a 
T-piece (preferred) or through a catheter
inserted through the endotracheal tube and 
placed above the carina.* 
Observe continuously for any spontaneous 
breathing. 
Halt testing if: 
- Spontaneous respirations are witnessed;
- Systolic blood pressure <100 mm Hg or 
mean arterial pressure <60 mm Hg despite
titration of inotropes/vasopressors; 
- Sustained oxygen desaturation <85%;
- An unstable arrhythmia occurs.
It is suggested that prior to aborting the 
apnoea test due to cardiorespiratory instability, 
an arterial blood gas (ABG) be sent for testing. 
If the PaCO2 target is met, the apnoea test can 
be considered positive (consistent with brain 
death). 
Interpretation: 
In cases of brain death, apnoea must be 
demonstrated in the presence of an adequate 
stimulus to spontaneous ventilation, i.e. an 
arterial PaCO2 >60 mmHg (8 kPa) and an 
arterial pH<7.30. 
In patients with pre-existing hypercapnia, it is 
recommended to wait for a PaCO2 rise of >20 
mmHg (2.7 kPa) above the chronic level, with 
a pH<7.30. 
Attempt at breathing is defined as any 
respiratory muscle activity that results in 
abdominal or chest excursions or activity of 
accessory respiratory muscles. 
Duration (Target PaC02) 
The period of observation to achieve an 
adequate threshold of stimulus of the 
respiratory centre is variable. 
Usually PaCO2 rises by -3 mmHg (0.4 kPa) for 
every minute of apnoea. 
If starting from normocapnia, the PaCO2 is 
likely to be >60 mmHg (8 kPa) after 10 
minutes. 
If this is not the case at 10 minutes and the 
patient is stable, wait a further 5 minutes and 
repeat the arterial blood gas. 
An option to minimise the time required for the 
PaCO2 to rise to the desired level, is to adjust 
the minute ventilation to mild hypercarbia 
(PaCO2 -45 mmHg [6 kPa]) beforehand. 
If unable to complete testing, consider: 
If hypoxia occurs 1-2 positive pressure 
breaths can be given, and apnoea testing 
continued. 
Adequate pre-oxygenation and recruitment 
usually avoids this problem. 
*If using a catheter through the endotracheal tube supply oxygen at 4 - 6 L/min.
Fig. 3. Summary recommendations – Apnoea testing (https://criticalcare.org.za/resource/death-determination-checklists/).
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CIRCULATORY DEATH CERTIFICATION 
Summary Recommendations - South African Death Determination Guidelines Checklist 
Name: Hospital Number: Date of Birth: --------
Prerequisites 
Inappropriate to attempt cardiopulmonary resuscitation or attempts at cardiopulmonary 
resuscitation have failed 
Intensive support (ventilation, inotropes) withdrawn at ____ (time) on 
__ / ___ / _____ (date) 
Examination 
Absence of mechanical cardiac function confirmed by one of the following: 
- Absence of central pulse/ heart sounds on auscultation
- Absence of pulsatile flow on intra-arterial BP monitoring
- Absence of contractile activity on echocardiography
Patient observed for 5 minutes with no respiratory or circulatory activity seen* 
At end of 5 minutes observation period, lack of pupillary response to light and 













*Any spontaneous return of circulatory or respiratory activity during the 5-minute observcation period requires a reset of the 
observation period from this point 
** In cases of possible organ donation after circulatory death one doctor with more than 5 years experience, 
neither doctor may be involved with the transplant team. 
Fig. 4. Summary recommendation – Circulatory death certification checklist (https://criticalcare.org.za/resource/death-determination-checklists/).
